Sonia S Anand
Statistics and Probability · 2000–2020
A researcher in the Science corpus: 21 papers; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Statistics and Probability — 19 citations into it
Whom Sonia S Anand trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Papers from Sonia S Anand's perspective
Ordered by how strongly the researchers Sonia S Anand trusts endorse each paper. Same corpus, a different order for every researcher.
- Prospective studies collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies (vol 360,…
- Role of Built Environments in Physical Activity, Obesity, and Cardiovascular Disease (Circulation)
- Epidemiology of Heart Failure (Circulation Research)
- Interpretation of the evidence for the efficacy and safety of statin therapy. (The Lancet)
- Association between omega-3 fatty acid supplementation and risk of major cardiovascular disease events: a systematic review and meta-analysis. (Journal of the American Medical Association (JAMA))
- Risk factors for congestive heart failure in US men and women: NHANES I epidemiologic follow-up study. (Archives of Internal Medicine)
- Policy: Sustainable development goals for people and planet (Nature)
- Systematic review and meta-analysis of the adverse health effects of ambient PM2.5 and PM10 pollution in the Chinese population. (Environmental Research)
- Air Pollution and Mortality in the Medicare Population (New England Journal of Medicine)
- Body-Mass Index and Mortality among 1.46 Million White Adults
Their papers
- Genome-wide association of early-onset myocardial infarction with common single nucleotide polymorphisms, common copy number variants, and rare copy number variants (2009) — 1,094 citations
- A comprehensive 1000 Genomes-based genome-wide association meta-analysis of coronary artery disease (2015) — 2,034 citations
- Rivaroxaban in Peripheral Artery Disease after Revascularization. (2020) — 737 citations
- Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial. (2018) — 696 citations
- Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease (2017) — 2,009 citations
- Associations of fats and carbohydrate intake with cardiovascular disease and mortality in 18 countries from five continents (PURE): a prospective cohort study. (2017) — 943 citations
- Reducing the Global Burden of Cardiovascular Disease, Part 1: The Epidemiology and Risk Factors. (2017) — 929 citations
- Intake of saturated and trans unsaturated fatty acids and risk of all cause mortality, cardiovascular disease, and type 2 diabetes: systematic review and meta-analysis of observational studies (2015) — 1,308 citations
- Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study (2012) — 2,232 citations
- A genome-wide association study in Europeans and South Asians identifies five new loci for coronary artery disease (2011) — 669 citations
- Large-scale association analyses identifies 13 new susceptibility loci for coronary artery disease (2011) — 1,948 citations
- Association of Diet, Exercise, and Smoking Modification With Risk of Early Cardiovascular Events After Acute Coronary Syndromes (2010) — 633 citations
- A systematic review of the evidence supporting a causal link between dietary factors and coronary heart disease. (2009) — 1,365 citations
- Risk factors for myocardial infarction in women and men: insights from the INTERHEART study. (2008) — 908 citations
- Waist circumference and waist-to-hip ratio as predictors of cardiovascular events: meta-regression analysis of prospective studies. (2007) — 1,095 citations
- Adverse Impact of Bleeding on Prognosis in Patients With Acute Coronary Syndromes (2006) — 1,372 citations
- Emerging risk factors for atherosclerotic vascular disease: a critical review of the evidence. (2003) — 630 citations
- Global burden of cardiovascular diseases: part I: general considerations, the epidemiologic transition, risk factors, and impact of urbanization. (2001) — 3,051 citations
- Global burden of cardiovascular diseases: Part II: variations in cardiovascular disease by specific ethnic groups and geographic regions and prevention strategies. (2001) — 1,514 citations
- Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing, monitoring, efficacy, and safety. (2001) — 1,534 citations